Related Experiment Video
Updated: May 30, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma
Zhuomiao Ye1, Xin Li1, Fei Xie2
1Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC) and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, Chongqing University, Wanzhou District, Chongqing 404100, China; Chongqing Technical Innovation Center for Quality Evaluation and Identification of Authentic Medicinal Herbs, Wanzhou District, Chongqing 404100, China; School of Medicine Chongqing University, Chongqing University, Shapingba District, Chongqing 400030, China.
None:
NUT carcinoma is a rare and highly aggressive malignancy, predominantly affecting adolescents and young adults. This tumor demonstrates rapid progression, resistance to conventional anti-cancer treatments, and an extremely poor prognosis. Currently, research on NUT carcinoma is limited, and effective treatment options remain scarce. In this study, we performed single-cell RNA sequencing (scRNA-seq) on tumor tissue from a 13-year-old patient with maxillary sinus NUT carcinoma. The analysis revealed significant heterogeneity among epithelial cells within the tumor microenvironment (TME). Immune cell infiltration was notably low, suggesting that the tumor represents a "cold" immune microenvironment. Subclustering of epithelial cells identified distinct subpopulations characterized by high proliferation, metabolic activity, TGF-Beta-driven invasiveness, and MYC-driven growth and protein secretion. These findings provide critical insights into the tumor's biology, growth mechanisms, and potential therapeutic vulnerabilities. This study highlights the importance of scRNA-seq in understanding the complexity of NUT carcinoma and underscores the need for personalized treatment approaches, including the potential application of BET inhibitors.

